Introducing the Levita
Robotic Surgery Platform
The Levita Robotic Surgery Platform is not yet available for commercial sale.
Less pain, faster recovery, and fewer incisions with Magnetic Surgery.
Improved visualization and complete control over laparoscopic instruments.
Increased procedure volume and efficiency with less burden on personnel.
Levita Magnetics Secures $26M to Advance Disruptive Surgical Robotic System
View Press Release
Series C financing to support regulatory process and initial market entry of the Levita® MARS™ platform designed to make robotic surgery accessible for all
World's First Magnetic Robotic-Assisted Surgeries Performed with Levita Magnetics' Newest Platform
View Press Release
Our ultimate goal is to globally increase the ability of surgeons and hospitals to provide more patients access to better surgical procedures within their communities.
—Dr. Alberto Rodriguez-Navarro, founder and CEO of Levita Magnetics
Levita® Magnetics Introduces the First Magnetic Surgical Platform
Designed to magnetically grasp and retract the target tissue in laparoscopic cholecystectomy, bariatric and prostatectomy procedures, eliminating the need for a dedicated trocar and shafted instrumentation that may clutter the operative field and enabling reduced-port procedures.
news & awards
We're evolving minimally invasive surgery
At Levita Magnetics, our mission is to enhance patient outcomes by minimizing the footprint of surgical procedures across multiple indications and broad patient populations.
We know surgical innovation
Less Invasive Solutions
With several minimally invasive options available, surgeons and patients are more focused than ever on reducing surgical trauma while maximizing cosmetic results.
Leading the Way
Levita Magnetics is leading the way in developing a shaftless Magnetic Surgery platform that enables a reduced number of trocars in laparoscopic cholecystectomy, bariatric and prostatectomy procedures.
Making a Difference
We are committed to working tirelessly with our physician partners and health care providers to make the use of these new and innovative magnetic surgical platforms commonplace, so that together, we can make a difference in each patient’s quality of life.
ALBERTO RODRIGUEZ-NAVARRO, M.D.
Minimally invasive general surgeon with more than ten years of clinical experience. Medical inventor with multiple patents and clinical researcher with publications in international journals, especially in the field of post-operatory pain.
Twenty-five years of product development and operations experience. Leadership roles at Verily Life Sciences (founding member), Google[x], Google, Acclarent/JnJ, and Guidant/Boston Scientific. BS and MS in Mechanical Engineering from Stanford University.
Senior Director, Operations
Twenty-five years of medical device engineering and operations experience. Held leadership roles in engineering and manufacturing at Heartport, Johnson & Johnson, Concentric Medical and Stryker Neurovascular. BS in Mechanical Engineering from The Ohio State University.
Executive level Regulatory Affairs and Clinical Research professional with over 30 years of experience and expertise. Former Senior Vice President/Vice President of Regulatory Affairs and Clinical Research for Conceptus and Kyphon.
Former President and CEO of Aegea Medical. Over 25 years of experience in commercial and leadership positions in the medtech industry. Previously served as the President and CEO of Cardiokinetix, President and CEO of Concentric Medical, Inc., and President of the Cardiac Surgery division of Guidant Corporation. Maria currently serves on the board of Directors of several medical technology companies.
ALBERTO RODRIGUEZ-NAVARRO, M.D.
Minimally invasive general surgeon with more than ten years of clinical experience. Medical inventor with multiple patents and clinical researcher with publications in international journals, especially in the field of post-operative pain.
Managing Partner at Aurus Capital focusing on early stage biotech, pharma, and medtech investments. Previously worked at Athelera LLC with responsibility for mergers and acquisitions in Latin America and Europe. Served as a consultant for the Boston Consulting Group.
Founder, CEO of Avail Medsystems, Inc. Prior to founding Avail, Daniel held roles in both large and emerging companies including Advanced Cardiovascular Systems, Inc. (NYSE: ABT) and Intuitive Surgical (NASDAQ: ISRG) where he joined as the 6th employee. Daniel is a co-founder of Calibra Medical (CeQur), and founder of Shockwave Medical, Inc. (NASDAQ: SWAV), where he invented Intravascular Lithotripsy (IVL) and served as CEO. Daniel is a named inventor on over 160 patents and applications and three times named one of the “100 most Intriguing Entrepreneurs” by Goldman Sachs.
Current Founder and Managing Partner of SPRIG Equity. Over 20 years of experience in commercial and investing positions in the healthtech industry. Previously served as General Partner of Accelmed Partners, Divisional Vice President of Abbott Ventures, and Principal of ONSET Ventures. Additionally, worked in operating roles with Acclarent, Johnson & Johnson, and Stryker Corporation.